Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian markets shed early gains
Wed, 4 Feb 11:30 am

Indian stock markets shed their initial gains over the last two hours of trade and are trading flat. Sectoral indices are trading mixed with metal and pharma stocks leading the gains while auto and capital goods are the leading losers.

The BSE-Sensex is down by 20 points and NSE-Nifty is down by 7 points. BSE Mid Cap index is trading flat and BSE Small Cap index is trading up 0.3%. The rupee is trading at 61.73 to the US dollar.

Oil & Gas stocks is trading on a positive note with Cairn India and ONGC being the leading gainers. According to a leading financial daily, the government has decided to exempt upstream oil companies ONGC and Oil India from paying fuel subsidy as long as the crude prices remain below US$ 60 a barrel and proposed to exclude GAIL India from paying any more subsidy this fiscal. The decision comes following a sharp decline in oil prices. State-run oil marketing companies suffer under recovery for selling fuels such as kerosene and LPG at a subsidized cost. There is also an outstanding subsidy of Rs 109 bn on diesel.

Healthcare stocks are all trading in the green barring a few stocks like Aurobindo Pharma and Divis Lab. Ranbaxy Lab and Sun Pharma are the leading gainers. According to a leading financial daily, seven Indian generic pharmaceutical companies have been recommended for suspension by the European Medicines Agency (EMA). The decision follows after questions were raised over the integrity of clinical research data generated at a site operated by Hyderabad-based GVK Biosciences. While the list of suspended medicines comprise the names of several major global generic drug makers, including Teva and Mylan, at least a dozen drugs marketed by Indian companies and their subsidiaries have also been figured in this list.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Indian markets shed early gains". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Mar 22, 2018 (Close)